A study that looked at tests from 300 U.S. labs found community-acquired MRSA made up 28.2% of resistant staph infections in 2006, up from 3.6% in 1999. Researchers also found that more than half of all staph cases seen at the labs serving hospitals are immune to drugs commonly used to treat them.

Related Summaries